Category: ACN Newswire

Theinvestmedia.com Offers Exclusive Brokerage Account Opening Offers and In-Depth Tutorials, Empowering Investors with Precise Decision-Making

acn

HONG KONG, July 26, 2025 – (ACN Newswire via SeaPRwire.com) – As one of the leading stock brokerage account opening offers comparison and practical investment education media platform in Hong Kong and Asia, Theinvestmedia.com ( https://theinvestmedia.com ) today proudly announced the exclusive update and launch of its fully optimized “Brokerage Account Opening Offers” special section on its website. […]

維立志博於聯交所主板成功上市

acn

香港，2025年7月25日 – (亞太商訊 via SeaPRwire.com) – 下一代肿瘤免疫疗法的领跑者 – 南京維立志博生物科技股份有限公司(「維立志博」或「公司」，股份代號：9887.HK)，宣佈於香港聯合交易所有限公司（「香港聯交所」）主板上市，股票代號爲9887.HK…

百仕達（1168）擬更名「Z Fin Limited」控股股東換股以行動彰顯信心和支持 轉型戰略升級前景看俏

acn

香港，2025年7月25日 – (亞太商訊 via SeaPRwire.com) – 百仕達控股有限公司（1168）於前天（7月23日）發佈公告，建議將公司名稱更改為「Z Fin Limited」，正式宣告其戰略的全面升級。緊隨其後，公司確認已收到控股股東的正式通知，將行使其全部可換股債券。 這…

Ultraman Omega joins the battlefield alongside beloved Ultraman Arc in Tsuburaya Production’s new Starter Deck 03 ‘Ω to the Future’ and Booster Pack 4 ‘Gleam of Eternal Hope’

acn

Starter Deck 03 ‘Ω to the Future’ marks the highly anticipated debut of Ultraman Omega in card form, featuring exclusive cards and brand new strategies that bring the latest TV series to life and allowing fans to experience the title hero’s journey. Booster Pack 04 ‘Gleam of Eternal Hope’ introduces powerful new versions of iconic […]

Multi-Dose Diquafosol Sodium Eye Drops Obtained Approval from NMPA for Commercialisation in China

acn

HONG KONG, July 25, 2025 – (ACN Newswire via SeaPRwire.com) – Essex Bio-Technology Limited (“Essex” or the “Group”, Stock Code: 1061.HK) is pleased to announce that (Zhuhai Essex Bio-Pharmaceutical Company Limited), an indirect wholly-owned subsidiary, has received approval from (National Medical Products Administration) for the registration and commercialisation of the multi-dose Diquafosol Sodium Eye Drops […]

Everest Medicines Announces Share Placement to Raise Approximately HK$1,572.50 Million

acn

SHANGHAI, July 25, 2025 – (ACN Newswire via SeaPRwire.com) – Everest Medicines (HKEX 1952.HK, “Everest” or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into a placing and subscription agreement with the placing agents and its controlling shareholder, CBC Group […]

31 Concept Emerges From Stealth Mode, to Unveil Groundbreaking Network Intelligence Platform at Iss Asia 2025

acn

DUBAI, July 21, 2025 – (ACN Newswire via SeaPRwire.com) – 31 Concept (31C), a technology startup specializing in advanced network intelligence and traffic visibility solutions, today officially announces its emergence from stealth mode. Following a successful $6 million pre-seed funding round in December 2024, the company has grown to a team of 35 world-class professionals and […]

HKTDC Research Report: Exploring Opportunities in Hong Kong’s Proprietary Chinese Medicine Industry

acn

– The implementation of streamlined approval procedures for Hong Kong- and Macao-registered proprietary Chinese medicines (“pCms”) by mainland China presents significant opportunities for Hong Kong companies to expand into the Greater Bay Area and other mainland market.– A unified and comprehensive registration system strengthens the quality control of Hong Kong’s pCms, reinforcing confidence among other […]

Avantor Relocates Korea Office in Suwon to Support Growth and Enhance Collaboration

acn

Suwon, South Korea, July 24, 2025 – (ACN Newswire via SeaPRwire.com) – Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, has inaugurated its new office in Suwon, Korea. The office relocation reflects Avantor’s continued investment in the Asia Pacific region and its commitment […]